A pharmaco clinical study of shunthi (zingiber officinale roxb) in the management of amavata w.s.r to rheumatoid arthirtis
International Journal of Development Research
A pharmaco clinical study of shunthi (zingiber officinale roxb) in the management of amavata w.s.r to rheumatoid arthirtis
Received 03rd March, 2017; Received in revised form 29th April, 2017; Accepted 17th May, 2017; Published online 16th June, 2017
Copyright© 2017, Milan Jayantibhai Prajapati. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction: Amavata occurs in all over the world in all races, sexes, age and climates and is equated with Rheumatoid Arthritis. It is one of the main ailments of modern era of sedentary life style due to its crippling, lingering and relapsing nature. According to Modern system of Medicine, Amavata can be compared to Rheumatoid Arthritis (R.A.). R.A is auto immune disease Aim: To evaluate the role of Shunthi Churna in the disease Amavata. Material and Methods: Total 30 patients of age group 20-60 years were registered in Group A. Assessment was done based Classical signs and symptoms of the disease according to Ayurveda as well as modern medical science will be consider like Jones criteria (Major and minor) for Rheumatoid arthritis. The data obtained in clinical study was analysed by using Paired t test. Result: In Sandhi ruja percentage of Reduction is 37.03%. , In Sparshasahatva percentage of Reduction % is 41.45%. In Stabdhata percentage of Reduction % is 40.32%., for Walking time percentage of Reduction % is 38.65%. ,for VAS(Visual Analog Scale) percentage of Reduction % is 28.8% Conclusion: Sunthi churna with Anupana of Ushna Jala shows significant effect in Amavata.
